Shefali Kakar
Seminars
Wednesday 2nd December 2026
Defining the Right Dose Without Individualisation: Can Clinical Pharmacology & Dosimetry Deliver More Predictable Radioligand Therapy Outcomes?
1:30 pm
- Reviewing the dose selection strategies underpinning currently approved radioligand therapies and evaluating what these programmes have taught us about efficacy, safety and treatment optimisation
- Exploring how developers can use clinical pharmacology and dosimetry data to establish robust dose strategies across diverse patient populations
- Understanding the trade-offs between personalised treatment approaches and operationally scalable dosing paradigms
